Skip to main content

Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration.

Publication ,  Journal Article
Degan, S; May, BL; Jin, YJ; Ben Hammouda, M; Sun, H; Zhang, G; Wang, Y; Erdmann, D; Warren, W; Zhang, JY
Published in: Front Oncol
2024

[This corrects the article DOI: 10.3389/fonc.2022.782877.].

Duke Scholars

Published In

Front Oncol

DOI

ISSN

2234-943X

Publication Date

2024

Volume

14

Start / End Page

1418213

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Degan, S., May, B. L., Jin, Y. J., Ben Hammouda, M., Sun, H., Zhang, G., … Zhang, J. Y. (2024). Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration. Front Oncol, 14, 1418213. https://doi.org/10.3389/fonc.2024.1418213
Degan, Simone, Brian L. May, Yingai J. Jin, Manel Ben Hammouda, Huiying Sun, Guoqiang Zhang, Yan Wang, Detlev Erdmann, Warren Warren, and Jennifer Y. Zhang. “Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration.Front Oncol 14 (2024): 1418213. https://doi.org/10.3389/fonc.2024.1418213.
Degan S, May BL, Jin YJ, Ben Hammouda M, Sun H, Zhang G, et al. Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration. Front Oncol. 2024;14:1418213.
Degan, Simone, et al. “Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration.Front Oncol, vol. 14, 2024, p. 1418213. Pubmed, doi:10.3389/fonc.2024.1418213.
Degan S, May BL, Jin YJ, Ben Hammouda M, Sun H, Zhang G, Wang Y, Erdmann D, Warren W, Zhang JY. Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration. Front Oncol. 2024;14:1418213.

Published In

Front Oncol

DOI

ISSN

2234-943X

Publication Date

2024

Volume

14

Start / End Page

1418213

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis